MDMA gets a boost in Australia

Making novel psychedelics down under

Emyria is an Australian biotech company that is developing treatments for unmet medical needs. One of their development programs has made over 125 MDMA analogues. The work has been done in collaboration with Matt Piggott at the University of Western Australia (UWA).

Not PTSD (initially), but fibromyalgia

Though Emyria plans to explore MDMA analogues for PTSD, their initial target will be fibromyalgia.

Implementing psychedelics in the real world

One thing that stands out for Emyria is the company’s focus on real-world data.



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store



Psychedelics information for everyone. Making info about psychedelics more accessible!